Mizuho downgraded Hologic (HOLX) to Neutral from Outperform with a $78 price target after the company agreed to be acquired by funds managed by Blackstone (BX) and TPG (TPG) in a transaction valued at up to $79 per share, representing an enterprise value of up to $18.3B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HOLX:
- Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
- Wall Street Hits Pause on Hologic Stock (HOLX) after $18B Buyout Offer
- Hologic downgraded to Equal Weight from Overweight at Stephens
- Hologic downgraded to Neutral from Overweight at JPMorgan
- Hologic downgraded to Market Perform from Outperform at Raymond James